Sinopharm Group Co Ltd - Company Profile
Powered by
All the data and insights you need on Sinopharm Group Co Ltd in one report.
- Save hours of research time and resources with
our up-to-date Sinopharm Group Co Ltd Strategy Report
- Understand Sinopharm Group Co Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Sinopharm Group Co Ltd (Sinopharm), a subsidiary of China National Pharmaceutical Group Corp, distributes pharmaceutical and healthcare products. The company provides distribution, logistics and other value-added services to foreign and domestic manufacturers and suppliers of pharmaceuticals, medical products and supplies, and other healthcare products. It serves hospitals, primary health service institutions, and retail drug stores. Sinopharm also manufactures and sells pharmaceuticals, chemical reagents, laboratory supplies, and carries out the development of pharmaceutical, medical services, and other health-related industries. The company manages a chain of medicine stores in China through direct operations and franchises to market pharmaceutical and healthcare products. Sinopharm is headquartered in Shanghai, China.
Sinopharm Group Co Ltd premium industry data and analytics
Products and Services
Products | Services |
---|---|
Laboratory Supplies | Retail Drug Stores |
Chemical Reagents | Pharmaceutical and Healthcare Products Distribution and Logistics |
Medical Equipments | |
XYZ | |
XYZ | |
XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
Year | Event | Description |
---|---|---|
2024 | Corporate Changes/Expansions | In March, the company changed its address from 1st Floor, No.385 East Longhua Road, Huangpu District, Shanghai, the PRC to 1st and 11th to 15th Floors, No.385 East Longhua Road, Huangpu District, Shanghai, the PRC. |
2023 | Plans/Strategy | In August, the company announced its plans to acquire Neuca. |
2023 | Contracts/Agreements | In March, the company signed a joint venture with Elekta to increase the adoption of radiation therapy in lower-tier cities. |
Competitor Comparison
Key Parameters | Sinopharm Group Co Ltd | Shanghai Fosun Pharmaceutical (Group) Co Ltd | China Resources Sanjiu Medical & Pharmaceutical Co Ltd | Tasly Pharmaceutical Group Co Ltd | Wai Yuen Tong Medicine Holdings Ltd |
---|---|---|---|---|---|
Headquarters | China | China | China | China | Hong Kong |
City | Shanghai | Shanghai | Shenzhen | Tianjin | Hong Kong |
State/Province | Shanghai | Shanghai | Guangdong | Tianjin | - |
No. of Employees | 115,959 | 40,370 | 20,318 | 9,223 | 1,962 |
Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
Name | Position | Board | Since | Age |
---|---|---|---|---|
Yu Qingming | Chairman | Executive Board | 2021 | 59 |
Li Xiaojuan | Chief Financial Officer | Senior Management | 2021 | 47 |
Liu Yong | Director; President | Executive Board | 2017 | 54 |
Wang Peng | Supervisor | Senior Management | - | 40 |
Wu Yijian | Secretary | Senior Management | 2019 | 53 |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer